|
Re: Zenith abstract to be presented at AACR meeting 11/30
|
2
|
Zenith Epigenetics
|
Dec 06, 2016 11:44PM
|
|
Re: ZEN-3694 & Enzalutamide Combo Trial Now Recruiting
|
4
|
Zenith Epigenetics
|
Dec 07, 2016 12:01AM
|
|
Re: Zenith Capital Corp. Announces Annual and Special Meeting Webcast Details
|
2
|
Zenith Epigenetics
|
Dec 07, 2016 09:06PM
|
|
Re: AGM
|
7
|
Resverlogix Corp.
|
Dec 08, 2016 10:28AM
|
|
Re: We are owed....
|
4
|
Resverlogix Corp.
|
Dec 08, 2016 10:42AM
|
|
Resverlogix to present at Biotech Showcase in January
|
|
Resverlogix Corp.
|
Dec 08, 2016 02:54PM
|
|
Zenith to present at Biotech Showcase in January
|
1
|
Zenith Epigenetics
|
Dec 08, 2016 02:56PM
|
|
Re: Resverlogix to present at Biotech Showcase in January
|
1
|
Resverlogix Corp.
|
Dec 09, 2016 10:06AM
|
|
RVX-208 and Rosuvastatin Patent
|
8
|
Resverlogix Corp.
|
Dec 12, 2016 05:01PM
|
|
Re: RVX-208 and Rosuvastatin Patent
|
2
|
Resverlogix Corp.
|
Dec 13, 2016 02:39PM
|
|
biOasis AGM and Special Meeting set for Jan. 23, 2017
|
|
BIOASIS TECHNOLOGIES INC
|
Dec 13, 2016 04:46PM
|
|
Zenith Announces Initiation of Phase 1b ZEN-3694 Trial
|
3
|
Zenith Epigenetics
|
Dec 14, 2016 11:18AM
|
|
Re: Zenith Announces Initiation of Phase 1b ZEN-3694 Trial
|
3
|
Zenith Epigenetics
|
Dec 14, 2016 11:40AM
|
|
Re: Resverlogix to present at Biotech Showcase in January
|
|
Resverlogix Corp.
|
Dec 14, 2016 03:58PM
|
|
Re: Zenith to present at Biotech Showcase in January
|
|
Zenith Epigenetics
|
Dec 14, 2016 03:58PM
|
|
Re: Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide)
|
3
|
Zenith Epigenetics
|
Dec 14, 2016 05:36PM
|
|
Re: Zenith Announces Initiation of Phase 1b ZEN-3694 Trial
|
2
|
Zenith Epigenetics
|
Dec 14, 2016 05:46PM
|
|
Thanks in advance.....
|
1
|
Resverlogix Corp.
|
Dec 15, 2016 10:40AM
|
|
Thanks in advance....
|
1
|
Zenith Epigenetics
|
Dec 15, 2016 10:40AM
|
|
Resverlogix Corporate Update Slide Deck
|
1
|
Resverlogix Corp.
|
Dec 15, 2016 11:23AM
|
